PHAP (CT) Blocking Peptide

Home/Control Peptides/PHAP (CT) Blocking Peptide

Pricing & Details

Product No.P217
Formats AvailableView All
Product Type
Blocking Peptide
Alternate Names
Putative HLA-DR-Associated Protein
Prod No.
Add to cart
P217-50 µg
50 µg
In stock
Min: 1
Step: 1
Contact Us For Academic mAb Advantage Pricing

Antibody Details

Product Details

Reactivity Species
Product Concentration
0.2 mg/ml
Amino Acid Location
Carboxy terminus of human PHAP.
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
Next Day Ambient
Amino Acid Sequence
Amino acids near the carboxy terminus of human PHAP.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
PHAP peptide is applicable as a control peptide for blocking antibody binding in Western blotting.

Antigen Details


References & Citations

1. Jaffer ZM and Chernoff J. p21-activated kinases: three more join the Pak. Int. J. Biochem. Cell Biol. 2002; 34:713-7. 2. Dan C, Nath N, Liberto M, et al. PAK5, a new brain-specific kinase, promotes neurite outgrowth in N1E-115 cells. Mol. Cell. Biol. 2002; 22:567-77. 3. Cotteret S, Jaffer ZM, Beeser A, et al. p21-activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylated BAD. Mol. Cell. Biol. 2003; 23:5526-39.
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy. Ok